Poor Facial Skin ComplexionNCT07900308
A Clinical Study to Assess the Effectiveness of the Hyper Glow Serum on Skin Complexion and Hydration
A study testing Hyper Glow Serum in people with Poor Facial Skin Complexion and Skin Hydration, run by Dime Beauty Co. at 1 site in United States.
Trial summary
This single-group, open-label, virtual clinical trial will evaluate the effectiveness of the Hyper Glow Serum by DIME Beauty on skin complexion and hydration in 35 female participants over 60 days. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Poor Facial Skin Complexion, Skin Hydration, Skin Texture
- What is being tested?
- Hyper Glow Serum
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 35 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Mar 2024to 31 May 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Female
- Individuals aged 18-65
- Individuals with no known allergies to the product ingredients
- Individuals willing to comply with the study requirements
- Self-reported poor facial skin complexion
- Self-reported issues with skin hydration and tightness
Show all 10Show fewer
- Generally healthy - do not live with any uncontrolled chronic disease
- Must not use any other oil-based serums for the duration of the study
- Willing to maintain the same skincare products and routine for the duration of the study (apart from other serums)
- Has been using the same skincare products and routine for the past month
Who cannot join
- Individuals with known skin conditions or diseases of the face and neck
- Individuals currently on medication that affects skin health
- Individuals who have undergone facial cosmetic procedures in the past six months
- Any pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders
- Women who are pregnant, breastfeeding, or trying to conceive
- Anyone unwilling to follow the study protocol
- Anyone currently participating or planning to participate in a research study
Trial locations and contacts
1 site in 1 country.
About this study
This single-group, open-label, virtual clinical trial will evaluate the effectiveness of the Hyper Glow Serum by DIME Beauty on skin complexion and hydration in 35 female participants over 60 days. Participants will apply 3-5 drops of the serum to the face and neck each morning, with assessments conducted via self-reported questionnaires, expert skin grading, and before-and-after photographs at Baseline, Day 14, Day 30, and Day 60.
The primary objective is to examine the effect of daily use of the Hyper Glow Serum on overall skin complexion, including texture, evenness, and brightness. The secondary objective is to assess changes in participants' perception of skin hydration, tightness, and youthfulness over the 60-day intervention period.
- Being tested
- Hyper Glow Serum
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Hyper Glow SerumDietary supplement
All 35 enrolled female participants apply 3-5 drops of Hyper Glow Serum to the face and neck daily in the morning for 60 days. Participants cleanse (and optionally tone) before application. If irritation occurs, frequency is reduced to 3-4 times per week. Two bottles of product are provided, sufficient for the full 60-day duration.
| Study group | Role | What they receive |
|---|---|---|
| Hyper Glow Serum | Experimental | Not described Receives: Dietary Supplement: Hyper Glow Serum |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Skin Complexion (Texture)
Self-reported questionnaire measuring participant-perceived skin texture
Measured: Baseline, Day 14, Day 30, and Day 60
Change in Skin Complexion (Evenness)
Self-reported questionnaire measuring participant-perceived skin evenness
Measured: Baseline, Day 14, Day 30, and Day 60
Change in Skin Complexion (Brightness)
Self-reported questionnaire measuring participant-perceived skin brightness
Measured: Baseline, Day 14, Day 30, and Day 60
Expert Skin Grading of Overall Complexion
Expert-evaluated grading of overall skin complexion assessed from participant photographs
Measured: Baseline, Day 30, and Day 60
Secondary outcomes (6)
Change in Self-Reported Skin Hydration
Self-reported questionnaire measuring participant-perceived skin hydration
Measured: Baseline, Day 14, Day 30, and Day 60
Change in Self-Reported Skin Tightness
Self-reported questionnaire measuring participant-perceived skin tightness
Measured: Baseline, Day 14, Day 30, and Day 60
Change in Self-Reported Skin Youthfulness
Self-reported questionnaire measuring participant-perceived skin youthfulness
Measured: Baseline, Day 14, Day 30, and Day 60
Expert Skin Grading of Skin Hydration
Expert-evaluated grading of skin hydration, tightness, and youthfulness assessed from participant photographs
Measured: Baseline, Day 30, and Day 60
Expert Skin Grading of Tightness
Expert-evaluated grading of skin hydration, tightness, and youthfulness assessed from participant photographs
Measured: Baseline, Day 30, and Day 60
Expert Skin Grading of Youthfulness
Expert-evaluated grading of skin hydration, tightness, and youthfulness assessed from participant photographs
Measured: Baseline, Day 30, and Day 60
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Oct 2026
- Study start1 Mar 2024
- Primary completion31 May 2024
- Study completion31 May 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Poor Facial Skin ComplexionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 35 participants (actual)
Sponsor and investigators
- Lead sponsor
- Dime Beauty Co.
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Citruslabs
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07900308
- Sponsor's protocol ID
- 20388
- Other IDs
- legacy-20388
- Status last verified
- Oct 2026
- First submitted
- 21 Oct 2026
- Last updated
- 28 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 28 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Clinical Study to Assess the Effectiveness of the Hyper Glow Serum on Skin Complexion and Hydration
- ClinicalTrials.gov ID
- NCT07900308
- Acronym / sponsor ID
- 20388
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 35 participants (actual)
- Lead sponsor
- Dime Beauty Co.Industry (pharma, biotech, devices)
- Collaborators
- Citruslabs
- Study start
- 1 Mar 2024 (actual)
- Primary completion
- 31 May 2024 (actual)
- Study completion
- 31 May 2024 (actual)
- First posted
- 28 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This single-group, open-label, virtual clinical trial will evaluate the effectiveness of the Hyper Glow Serum by DIME Beauty on skin complexion and hydration in 35 female participants over 60 days. Participants will apply 3-5 drops of the serum to the face and neck each morning, with assessments conducted via self-reported questionnaires, expert skin grading, and before-and-after photographs at Baseline, Day 14, Day 30, and Day 60.
The primary objective is to examine the effect of daily use of the Hyper Glow Serum on overall skin complexion, including texture, evenness, and brightness. The secondary objective is to assess changes in participants' perception of skin hydration, tightness, and youthfulness over the 60-day intervention period.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Hyper Glow Serum | Experimental | Dietary Supplement: Hyper Glow Serum |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (10 listed)
- Female
- Individuals aged 18-65
- Individuals with no known allergies to the product ingredients
- Individuals willing to comply with the study requirements
- Self-reported poor facial skin complexion
Key exclusion criteria (7 listed)
- Individuals with known skin conditions or diseases of the face and neck
- Individuals currently on medication that affects skin health
- Individuals who have undergone facial cosmetic procedures in the past six months
- Any pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders
- Women who are pregnant, breastfeeding, or trying to conceive
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Hyper Glow SerumAll 35 enrolled female participants apply 3-5 drops of Hyper Glow Serum to the face and neck daily in the morning for 60 days. Participants cleanse (and optionally tone) before application. If irritation occurs, frequency is reduced to 3-4 times per week. Two bottles of product are provided, sufficient for the full 60-day duration. | Dietary supplement | Hyper Glow Serum |
Primary outcome
Change in Skin Complexion (Texture)
Time frame: Baseline, Day 14, Day 30, and Day 60
Self-reported questionnaire measuring participant-perceived skin texture
Change in Skin Complexion (Evenness)
Time frame: Baseline, Day 14, Day 30, and Day 60
Self-reported questionnaire measuring participant-perceived skin evenness
Change in Skin Complexion (Brightness)
Time frame: Baseline, Day 14, Day 30, and Day 60
Self-reported questionnaire measuring participant-perceived skin brightness
Expert Skin Grading of Overall Complexion
Time frame: Baseline, Day 30, and Day 60
Expert-evaluated grading of overall skin complexion assessed from participant photographs
6 secondary outcomes
Change in Self-Reported Skin Hydration
Time frame: Baseline, Day 14, Day 30, and Day 60
Change in Self-Reported Skin Tightness
Time frame: Baseline, Day 14, Day 30, and Day 60
Change in Self-Reported Skin Youthfulness
Time frame: Baseline, Day 14, Day 30, and Day 60
Expert Skin Grading of Skin Hydration
Time frame: Baseline, Day 30, and Day 60
Expert Skin Grading of Tightness
Time frame: Baseline, Day 30, and Day 60
Expert Skin Grading of Youthfulness
Time frame: Baseline, Day 30, and Day 60
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Oct 2026.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Hyper Glow Serum in people with Poor Facial Skin Complexion and Skin Hydration, run by Dime Beauty Co. at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 10 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Skin Complexion (Texture) (time frame: Baseline, Day 14, Day 30, and Day 60). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Oct 2026.